XR Pharmaceuticals Ltd

[Not Yet Scheduled]
XR Pharmaceuticals offers services of early computational drug discovery, target-to-hit. We use our original algorithm to calculate the structure of a ligand for arbitrary binding site in a biological macromolecule with resolved structure.

The calculated structure is then validated by estimating the binding affinity using publicly disclosed tools and protocols.

Our performance goals are:

To be able to develop a ligand with the highest theoretically possible affinity for any large chemical structure;

To eliminate the problem of non-druggable targets;

To output completely novel, patentable, scaffolds, which were neither synthesized yet nor found in the Nature;

To cut down the structure discovery time to 1-2 weeks;

To drastically cut down the costs of structure discovery.


Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
New Zealand
Year Founded:
2018
Main Therapeutic Focus:
Lead Product in Development:
Drug design algorithm
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Director
XR Pharmaceuticals Ltd.